SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 60 filers reported holding SCPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,030 | -85.1% | 2,111 | -78.7% | 0.00% | – |
| Q2 2023 | $100,993 | +875.5% | 9,911 | +586.4% | 0.00% | – |
| Q4 2022 | $10,353 | -94.1% | 1,444 | -94.7% | 0.00% | – |
| Q3 2022 | $176,000 | +2833.3% | 27,060 | +1946.9% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 1,322 | +102.1% | 0.00% | – |
| Q1 2022 | $4,000 | – | 654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |